Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Inogen Announces Second Quarter 2026 Financial Results
Inogen reported Q2 2026 revenue of $95.1 million, up 3% year-over-year, driven by a 14.8% increase in international sales, while U.S. sales and rentals declined.
Adjusted EBITDA turned positive at $2.4 million, leading the company to raise its full-year guidance to approximately $4.0 million, representing a 48% increase from 2025.
The company generated $2.9 million in operating cash flow, ended the quarter with $106.8 million in cash and no debt, and repurchased $7.5 million of shares.